Los Angeles Capital Management’s Astrana Health ASTH Stock Holding History
Bought
Maintained
Sold
Other funds holding ASTH
3C
Los Angeles Capital Management's ASTH Position: Q2 2026 in Review
Los Angeles Capital Management increased its Astrana Health (ASTH) stake by 8,942% in Q2 2026, buying an estimated $650K and bringing the position to 18,265 shares worth $848K. The position accounts for ﹤0.01% of the portfolio, ranked #780.
Los Angeles Capital Management first reported a position in ASTH in Q3 2022 and has held it in 7 quarters since. The position peaked at $1.36M in Q4 2022. 209 funds tracked by Wall St. Rank hold ASTH as of Q2 2026.
- Los Angeles Capital Management held 18,265 shares of Astrana Health worth $848K as of Q2 2026.
- Los Angeles Capital Management bought 18,063 Astrana Health shares in Q2 2026, an estimated $650K.
- Astrana Health made up ﹤0.01% of Los Angeles Capital Management's portfolio in Q2 2026, its #780 holding.
- Los Angeles Capital Management first reported a position in Astrana Health in Q3 2022 and has held it in 7 quarters since.
- Los Angeles Capital Management's Astrana Health position peaked at $1.36M in Q4 2022.
- 209 funds tracked by Wall St. Rank held Astrana Health as of Q2 2026.
Based on Los Angeles Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.